Advertisement

Skip to Content

The Week Ahead: Walgreens, McCormick, Lululemon Report

There are a handful of earnings on tap in a mostly quiet week. Plus consumption data.

Mar 24, 2018

Jeremy Glaser: It looks set to be a relatively quiet week.

Walgreens Boots Alliance reports on Wednesday. Analyst Vishnu Lekraj thinks the no-moat firm is fairly valued as it navigates through a pressured operating environment.

A trio of 2-star rated firms are on tap. Wide-moat McCormick has been posting solid growth, but Erin Lash sees it as pricey. Narrow-moat Lululemon has been riding the athleisure trend and has industry-leading gross margins, but this is already baked into the share price, says Bridget Weishaar. Sonia Vora describes narrow-moat beer, wine, and spirits company Constellation Brands as looking frothy.

Consumption data on Thursday, along with its underlying inflation gauge, is likely to be the most watched piece of economic data. The third estimate of fourth-quarter GDP and pending home sales are also on deck.

Stay tuned for our take on these stories.

Jeremy Glaser does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.

Securities Mentioned

Constellation Brands Inc Class A STZ	$224.81 +0.51%
Lululemon Athletica Inc LULU	$358.34 −0.75%
McCormick & Co Inc Registered Shs Non Vtg MKC	$80.65 −0.68%
Walgreens Boots Alliance Inc WBA	$34.50 +1.01%

Transparency is our policy. Learn how it impacts everything we do

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

How we make money

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your personal data

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

Verify your identity, personalize the content you receive, or create and administer your account.
Provide specific products and services to you, such as portfolio management or data aggregation.
Develop and improve features of our offerings.
Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

How we approach editorial content

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.